She is also an Assistant Member in the Clinical Research Division at the Fred Hutchinson Cancer Research Center. Her clinical practice focuses on patients with AML and myelodysplastic syndrome, in both the inpatient and outpatient setting. Dr. Percival is involved in the development and execution of clinical trials for AML patients, as well as in epidemiology research to help determine (and improve) the factors that affect survival and outcomes for AML patients.